Cargando…
A Phase I Randomized, Double-blind, Placebo-controlled Study on Efficacy and Safety Profile of a Sublingually Administered Cannabidiol /Delta 9-tetrahydrocannabidiol (10: 1) Regimen in Diabetes Type 2 Patients
The current study aimed to evaluate the safety profile and efficacy of a cannabis-based sublingual spray, CBDEX10(®) (containing 100 µg cannabidiol and 10 µg Δ(9)-tetrahydrocannabinol per puff; CBD/Δ(9)-THC 10:1), in improving lipid profile and glycemic state of the diabetic patients. Fifty diabetic...
Autores principales: | Afshar, Shima, Khalili, Shayesteh, Amin, Gholamreza, Abbasinazari, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Brieflands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024807/ https://www.ncbi.nlm.nih.gov/pubmed/36945340 http://dx.doi.org/10.5812/ijpr-132647 |
Ejemplares similares
-
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
por: Woelfl, Timo, et al.
Publicado: (2020) -
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
por: Hindocha, Chandni, et al.
Publicado: (2015) -
Randomized, double-blind, placebo-controled clinical trial of sublingual immunotherapy in natural rubber latex allergic patients
por: Gastaminza, Gabriel, et al.
Publicado: (2011) -
Effects of cannabidiol on behavioral and psychological symptoms of vascular dementia: a randomized, double-blind, placebo-controlled trial.
por: Pessoa, R. M. D. P. P., et al.
Publicado: (2023) -
The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment
por: Lawn, Will, et al.
Publicado: (2023)